close
International headquarters

Global Clinical Trial Planning and Design Services Market (2021-2030) – By Trial Phase, Service Type, Therapeutic Area, and Geography – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL THREAD)–The “Clinical Trial Planning and Design Services Market by Trial Phase, Service Type, Therapeutic Area, and Geography: Industry Trends and Global Forecast, 2021-2030” the report was added to ResearchAndMarkets.com offer.

This report presents an in-depth study of the current market landscape and the likely future potential of the Clinical Trial Planning and Design Services Market, over the next decade. The study also includes an in-depth analysis, highlighting the capabilities of various industry players engaged in this field.

It is a well-known fact that developing a new therapeutic intervention is both a long and expensive process. In fact, several reports have indicated that it can take around 10 years for a prescription drug to move from discovery to market, requiring investments of more than $ 2.5 billion.

It should be mentioned that clinical trials are an integral part of the overall drug development process, as they allow both innovators and regulators to assess the safety and efficacy of a candidate drug. The critical role of these studies can also be verified by the fact that they capture around 50% of the total time and cost investments made for the development of a drug candidate. However, the conduct of trials often faces several challenges, including scientific and operational complexity, concerns about recruiting and retaining suitable patients, issues with data processing, and increasingly stringent regulatory guidelines. In addition, the failure of a clinical trial can impose a huge financial burden on sponsors, estimated to range from $ 800 million (in the case of therapies with niche / limited applications) to $ 1.4 billion (for a drug that should be a blockbuster). It is further believed that a considerable part of the losses can be avoided by efficient test planning. In other words, efficient trial planning and design plays a critical role in enabling accurate, safe and rapid study execution at all sites.

Companies mentioned

  • ACI Clinic

  • SMA Korea

  • Alacrita

  • Algoric

  • Alison Heald Consulting

  • Anju software

  • Armstrong Clinic

  • AstraCrux clinical trial and advice

  • Globalization of Axeon biomedicine

  • Berry Consultants

  • Bio-debugging

  • BioepiNet

  • BioGenesis Health Center

  • Advice on organic products

  • International Biomedical Council

  • Biop

  • BioPoint

  • Biostatistics consultation center

  • Blueprint software systems

  • Boston Children’s Hospital

  • Brigham and Women’s Hospital

  • Cancer research and biostatistics

  • KERALAM TREATMENTS

  • SMS CATO

  • Biosciences CD

  • And many other companies!

Among other elements, the report includes:

  • A detailed overview of the overall market landscape of players engaged in providing clinical trial planning and design services, along with information on several relevant parameters such as year of establishment, company size, the location of the head office, the types of end users (pharmaceutical players, developers of medical devices and the biotechnology industry) and type of service (s) offered (PK / PD analysis, study design / development protocols, sample size and power analysis, development of a statistical analysis plan (SAP), development of a case report form (CRF), informed consent documents (DCI), randomization, investigator and site selection, study feasibility and regulatory support service).

  • An in-depth analysis of the competitiveness of the company of clinical trial planning and design service providers based on company strength (in terms of experience and company size) and strength portfolio of services (such as PK / PD analysis, study design / protocol development, sample size and power analysis, statistical analysis plan (SAP) development, form development case report (CRF), informed consent documents (ICD), randomization, investigator and site selection, study feasibility and regulatory support service).

  • Insightful analysis highlighting the cost reduction potential associated with clinical trial planning and design services.

  • An analysis of recent partnerships formed between various service providers offering clinical trial planning and design services. In addition, it includes a brief description of the different types of partnership models (such as clinical trial design agreements, licensing agreements and service alliances) that have been adopted by stakeholders engaged in this field, since 2016.

  • A detailed analysis of the various mergers and acquisitions carried out by the service providers engaged in this field, during the period 2016-2020, on the basis of several parameters (year of the agreement, type of agreement, intracontinental and intercontinental agreement , main drivers of value).

  • Exclusive 2×2 representation, highlighting the current market scenario (in terms of existing competition and growth opportunities) in emerging and established market segments.

Main topics covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. PRESENTATION

4. REGULATORY LANDSCAPE

5. MARKET LANDSCAPE

6. ANALYSIS OF THE COMPETITIVENESS OF THE COMPANY

7. COMPANY PROFILES

8. PARTNERSHIPS AND COLLABORATIONS

9. MERGERS AND ACQUISITIONS

10. ATTRACTIVENESS COMPETITIVENESS MATRIX

11. ANALYSIS OF COST SAVINGS

12. MARKET FORECASTS

13. SWOT ANALYSIS

14. FINAL REMARKS

15. MANAGEMENT OVERVIEW

16. APPENDIX I: LIST OF CROS

17. APPENDIX II: TABULATED DATA

18. APPENDIX III: LIST OF COMPANIES AND ORGANIZATION

For more information on this report, visit https://www.researchandmarkets.com/r/ioj7mp


Source link

Rodney N.

The author Rodney N.